Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)
CNY 8.97
(0.56%)
CNY 8.97
(0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.84 Billion | 2.33 Billion | 2.16 Billion | 1.7 Billion | 1.71 Billion | 1.46 Billion |
| Cost of Revenue | 664.62 Million | 503.37 Million | 432.41 Million | 361.08 Million | 376.21 Million | 291.16 Million |
| Gross Profit | 2.17 Billion | 1.82 Billion | 1.73 Billion | 1.34 Billion | 1.33 Billion | 1.17 Billion |
| Operating Expenses | 1.32 Billion | 1.01 Billion | 1.1 Billion | 889.55 Million | 928.91 Million | 825.68 Million |
| Selling, General and Administrative Expenses | 1.02 Billion | 767.61 Million | 841.74 Million | 706.8 Million | 725.37 Million | 664 Million |
| Research and Development Expenses | 264.18 Million | 166.01 Million | 166.53 Million | 128.76 Million | 120.09 Million | 87.31 Million |
| Other Expenses | -3.35 Million | 81.97 Million | 98.63 Million | 53.98 Million | 83.44 Million | -1.03 Million |
| Cost and Expenses | 1.94 Billion | 1.51 Billion | 1.53 Billion | 1.25 Billion | 1.3 Billion | 1.11 Billion |
| Operating Income | 923.97 Million | 841.99 Million | 660.06 Million | 424.04 Million | 401.77 Million | 310.62 Million |
| Interest Expense | 2.94 Million | 1.52 Million | 1.62 Million | 1.61 Million | 3.65 Million | 3.3 Million |
| Income Tax Expense | 61.34 Million | 96.12 Million | 91.73 Million | 69.6 Million | 53.01 Million | 44.84 Million |
| Earnings before Tax | 919.92 Million | 833.84 Million | 295.11 Million | 416.13 Million | 163.41 Million | 309.59 Million |
| Net Income | 847.22 Million | 703.26 Million | 206.62 Million | 358.95 Million | 124.46 Million | 263.17 Million |
| Earnings Per Share Basic | 0.52 | 0.43 | 0.13 | 0.22 | 0.08 | 0.17 |
| Earnings Per Share Diluted | 0.52 | 0.43 | 0.13 | 0.22 | 0.08 | 0.17 |
| Weighted Average Shares Outstanding | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.55 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.57 Billion |
| Gross Margin | 0.77 | 0.78 | 0.80 | 0.79 | 0.78 | 0.80 |
| EBIT Margin | 0.36 | 0.40 | 0.34 | 0.31 | 0.27 | 0.27 |
| Profit Margin | 0.30 | 0.30 | 0.10 | 0.21 | 0.07 | 0.18 |
| EBITDA | 1.02 Billion | 921.94 Million | 403.49 Million | 483.18 Million | 249.43 Million | 366.11 Million |
| Earnings Before Tax Margin | 0.33 | 0.36 | 0.30 | 0.25 | 0.23 | 0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 622.46 Million | 637 Million | 650.47 Million | 2.84 Billion | 836.86 Million | 734.1 Million |
| Cost of Revenue | 145.02 Million | 145.28 Million | 148.03 Million | 664.62 Million | 192.02 Million | 153.33 Million |
| Gross Profit | 477.43 Million | 491.71 Million | 502.44 Million | 2.17 Billion | 644.84 Million | 580.76 Million |
| Operating Expenses | 276.93 Million | 277.92 Million | 258.4 Million | 1.27 Billion | 505.97 Million | 273.84 Million |
| Selling, General and Administrative Expenses | 414.46 Million | 235.81 Million | 221.16 Million | - | 389.21 Million | 275.32 Million |
| Research and Development Expenses | 47.17 Million | 41.81 Million | 37.17 Million | - | 99.28 Million | 52 Million |
| Other Expenses | -184.7 Million | -290.73 Thousand | -68.67 Thousand | -5.81 Million | -17.47 Million | -590.81 Thousand |
| Cost and Expenses | 421.95 Million | 423.21 Million | 406.44 Million | 1.93 Billion | 697.99 Million | 427.18 Million |
| Operating Income | 206.36 Million | 213.79 Million | 244.03 Million | 905.47 Million | 138.86 Million | 304.85 Million |
| Interest Expense | 643.84 Thousand | 572.27 Thousand | 870.39 Thousand | 1.87 Million | 633.45 Thousand | 463.89 Thousand |
| Income Tax Expense | 30.11 Million | 32.57 Million | 35.67 Million | 61.34 Million | -41.81 Million | 41.51 Million |
| Earnings before Tax | 206.25 Million | 240.64 Million | 262.93 Million | 951.63 Million | 164.32 Million | 304.26 Million |
| Net Income | 173.58 Million | 198.38 Million | 217.74 Million | 847.22 Million | 192.81 Million | 258.05 Million |
| Earnings Per Share Basic | 0.11 | 0.12 | 0.13 | - | 0.12 | 0.16 |
| Earnings Per Share Diluted | 0.11 | 0.12 | 0.13 | - | 0.12 | 0.16 |
| Weighted Average Shares Outstanding | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion |
| Gross Margin | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.79 |
| EBIT Margin | 0.33 | 0.38 | 0.39 | - | 0.20 | 0.41 |
| Profit Margin | 0.28 | 0.31 | 0.33 | 0.30 | 0.23 | 0.35 |
| EBITDA | 206.9 Million | 244.17 Million | 253 Million | - | 166.41 Million | 302.85 Million |
| Earnings Before Tax Margin | 0.33 | 0.34 | 0.38 | 0.32 | 0.17 | 0.42 |
EMPPF
002596
TTW
PEBK
UNVB
SIGNATURE